Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Xylometazoline (0.05% w/v)
Therapeutic Category
Cold and Cough, General and OTC medicines, Pulmonary, Respiratory, ENT
Dosage Form
Nasal Spray
Packaging Type
with Outer
Packaging
10ml
Price
₹43/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Nosniff P Nasal Spray is an effective decongestant formulated to provide fast relief from nasal congestion in children aged 6 to 12 years. It contains Xylometazoline at a concentration of 0.05% w/v, which works by constricting the blood vessels in the nasal passages. This action reduces swelling and allows for easier breathing, helping alleviate discomfort caused by nasal blockages due to colds, allergies, or sinus infections.
This pediatric nasal spray is specifically designed to deliver targeted relief without systemic side effects. It ensures rapid action, offering up to 10-12 hours of congestion relief, allowing children to breathe more comfortably during the day and sleep better at night. Nosniff P Nasal Spray is easy to use, ensuring precise dosing with minimal wastage, making it a convenient and reliable choice for parents.
Possible side effects include mild nasal irritation, dryness, or a slight burning sensation. Overuse or prolonged use may lead to rebound congestion.
Used for temporary relief of nasal congestion associated with colds, allergies, and sinusitis in children aged 6 to 12 years.
Use only as directed by a healthcare professional. Avoid prolonged or excessive use to prevent dependency or rebound congestion.
Store at a temperature below 30°C in a cool, dry place. Keep away from direct sunlight and out of reach of children.
Composition : Xylometazoline (0.01% w/v)
Composition : Oxymetazoline (0.025% w/v)
Composition : Sodium Chloride I.P. 0.65% w/v + Benzalkonium Chloride Solution I.P. 0.02% w/v Nasal Drop
Composition : Fluticasone Furoate (50mcg)
Composition : Fluticasone Furoate (27.5mcg)
Composition : Fluticasone Furoate (27.5mcg) + Azelastine (140mcg)
Composition : Mometasone (50mcg)
Composition : Fluticasone Propionate (0.005% w/v)
Composition : Xylometazoline (0.1% w/v)
Composition : Formoterol (6mcg) + Fluticasone Propionate (250mcg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Xylometazoline 0.05% Nasal Spray is a topical nasal decongestant used for the relief of blocked nose due to cold, sinusitis, allergic rhinitis, and upper respiratory infections. It works by constricting nasal blood vessels, reducing swelling of nasal passages and improving breathing. It is widely used in ENT and respiratory care, making it a strong OTC + prescription fast-moving segment product in the pharma market.
Medical distributors and wholesalers can benefit from very high seasonal demand, especially during winter, monsoon, and allergy seasons. It is a fast-moving pharmacy product with strong repeat purchase behavior, ensuring consistent retail sales and quick stock turnover.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities in ENT, respiratory, and OTC nasal care segments with monopoly rights, quality manufacturing standards, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from high seasonal demand, strong retail pharmacy movement, and frequent usage in cold and allergy cases, making it a high-turnover and stable OTC category when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in ENT and respiratory OTC formulations can contact Cafoli Lifecare to discuss product availability, pricing structure, and PCD pharma franchise opportunities in the nasal care and respiratory segment.